Report overview
Wilson's Disease Drugs are used to reduce excessive copper in serum, indirectly reducing the accumulation of copper in various tissues of the body.
This report contains market size and forecasts of Wilson's Disease Drugs in Global, including the following market information:
Global Wilson's Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Wilson's Disease Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hepatic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Wilson's Disease Drugs include Kadmon Holdings, Inc., Merck & Co., Teva Pharmaceutical Industries Limited, Tsumura & Co., Valeant Pharmaceuticals International, Inc., VHB Life Sciences, Inc. and Wilson Therapeutics AB (Alexion), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Wilson's Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Wilson's Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Wilson's Disease Drugs Market Segment Percentages, by Type, 2021 (%)
Hepatic
Neuropsychiatric
Ophthalmic
Others
Global Wilson's Disease Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Wilson's Disease Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Wilson's Disease Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Wilson's Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Wilson's Disease Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Wilson's Disease Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Kadmon Holdings, Inc.
Merck & Co.
Teva Pharmaceutical Industries Limited
Tsumura & Co.
Valeant Pharmaceuticals International, Inc.
VHB Life Sciences, Inc.
Wilson Therapeutics AB (Alexion)
